79 related articles for article (PubMed ID: 9927993)
1. p22/PACAP response gene 1 (PRG1): a putative target gene for the tumor suppressor p53.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Ann N Y Acad Sci; 1998 Dec; 865():27-36. PubMed ID: 9927993
[TBL] [Abstract][Full Text] [Related]
2. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
[TBL] [Abstract][Full Text] [Related]
3. The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.
Schäfer H; Diebel J; Arlt A; Trauzold A; Schmidt WE
FEBS Lett; 1998 Oct; 436(2):139-43. PubMed ID: 9781666
[TBL] [Abstract][Full Text] [Related]
4. p22/PRG1: a novel early response gene in pancreatic cancer cells regulated by p53 and NF kappa B.
Schmidt WE; Arlt A; Trauzold A; Schäfer H
Ann N Y Acad Sci; 1999 Jun; 880():147-56. PubMed ID: 10415858
[No Abstract] [Full Text] [Related]
5. The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.
Schäfer H; Arlt A; Trauzold A; Hünermann-Jansen A; Schmidt WE
Biochem Biophys Res Commun; 1999 Aug; 262(1):139-45. PubMed ID: 10448082
[TBL] [Abstract][Full Text] [Related]
6. PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line.
Schäfer H; Trauzold A; Siegel EG; Fölsch UR; Schmidt WE
Cancer Res; 1996 Jun; 56(11):2641-8. PubMed ID: 8653710
[TBL] [Abstract][Full Text] [Related]
7. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
8. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
Saifudeen Z; Du H; Dipp S; El-Dahr SS
J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
[TBL] [Abstract][Full Text] [Related]
9. Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells.
Schäfer H; Lettau P; Trauzold A; Banasch M; Schmidt WE
Pancreas; 1999 May; 18(4):378-84. PubMed ID: 10231843
[TBL] [Abstract][Full Text] [Related]
10. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.
Huang YH; Wu JY; Zhang Y; Wu MX
Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
12. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
13. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
14. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
Shan B; Morris GF
Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
[TBL] [Abstract][Full Text] [Related]
15. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
Lin SR; Yang YC; Jung JH; Tsai JH
DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
[TBL] [Abstract][Full Text] [Related]
16. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
[TBL] [Abstract][Full Text] [Related]
17. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.
Arlt A; Grobe O; Sieke A; Kruse ML; Fölsch UR; Schmidt WE; Schäfer H
Oncogene; 2001 Jan; 20(1):69-76. PubMed ID: 11244505
[TBL] [Abstract][Full Text] [Related]
18. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
19. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1.
Rozenfeld-Granot G; Krishnamurthy J; Kannan K; Toren A; Amariglio N; Givol D; Rechavi G
Oncogene; 2002 Feb; 21(10):1469-76. PubMed ID: 11896574
[TBL] [Abstract][Full Text] [Related]
20. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
